UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

Precision Medicine Guided Treatment for Cancer Pain

Not Applicable

Completed

Conditions: CYP2D6 Polymorphism
Pain

Interventions: Genetic: CYP2D6
Behavioral: Brief Pain Inventory-Short Form (BPI-SF)
Behavioral: M.D. Anderson Symptom Inventory (MDASI)
Genetic: OPRM1

First Posted Date: 2016-01-27

Last Posted Date: 2019-01-14

Lead Sponsor: University of Florida

Target Recruit Count: 63

Registration Number: NCT02664350

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
🇺🇸
University of Florida, Gainesville, Florida, United States

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Phase 2

Terminated

Conditions: Glioblastoma
GBM
Glioblastoma Multiforme
Malignant Glioma

Interventions: Drug: Bevacizumab
Device: Optune
Other: Brain MRI
Other: Quality of Life Questionnaires

First Posted Date: 2016-01-26

Last Posted Date: 2022-06-23

Lead Sponsor: University of Florida

Target Recruit Count: 10

Registration Number: NCT02663271

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States

Responsive Deep Brain Stimulator for Essential Tremor

Not Applicable

Active, not recruiting

Conditions: Essential Tremor

Interventions: Device: Deep brain stimulation
Device: Closed-loop deep brain stimulation

First Posted Date: 2016-01-07

Last Posted Date: 2024-01-31

Lead Sponsor: University of Florida

Target Recruit Count: 20

Registration Number: NCT02649166

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Electromagnetic Tracking to Measure Tremor

Completed

Conditions: Tremor

Interventions: Device: Electromagnetic tracking
Procedure: Tremor kinetics before and after DBS
Procedure: Tremor kinetics after DBS

First Posted Date: 2015-12-29

Last Posted Date: 2017-10-26

Lead Sponsor: University of Florida

Target Recruit Count: 20

Registration Number: NCT02641366

Locations: 🇺🇸
Center for Movement Disorders and Neurorestoration, Gainesville, Florida, United States

Wearable Technology to Reduce Sedentary Behavior and CVD Risk in Older Adults

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Behavioral: Exercise
Behavioral: Non-Exercise Physical Activity (NEPA)

First Posted Date: 2015-12-16

Last Posted Date: 2018-11-23

Lead Sponsor: University of Florida

Target Recruit Count: 58

Registration Number: NCT02632487

Locations: 🇺🇸
UF Clinical Translational Research Building, Gainesville, Florida, United States

Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia

Early Phase 1

Recruiting

Conditions: Hypoxic Ischemic Encephalopathy

Interventions: Drug: Melatonin
Other: Magnetic Resonance Imaging
Other: Pharmacokinetics
Behavioral: Neurological Outcome Assessment

First Posted Date: 2015-12-04

Last Posted Date: 2024-08-21

Lead Sponsor: University of Florida

Target Recruit Count: 70

Registration Number: NCT02621944

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
Florida Hospital for Children, Orlando, Florida, United States

Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer

Not Applicable

Completed

Conditions: Insomnia
Genital Neoplasms, Female
Pain
Adaptation, Psychological

Interventions: Behavioral: Psychoeducation
Behavioral: Cognitive Behavioral Therapy

First Posted Date: 2015-11-20

Last Posted Date: 2023-06-15

Lead Sponsor: University of Florida

Target Recruit Count: 64

Registration Number: NCT02609880

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults

Withdrawn

Conditions: Chronic Kidney Disease
Acute Kidney Injury
Hypertension

Interventions: Drug: Iodohippurate
Procedure: 24 hour ambulatory Blood Pressure
Procedure: Peripheral Arterial Tonometry
Procedure: Pulse Wave Velocity
Drug: Gadolinium

First Posted Date: 2015-11-09

Last Posted Date: 2020-03-27

Lead Sponsor: University of Florida

Registration Number: NCT02599844

Severe Sepsis in Children - IMPRESS-C

Withdrawn

Conditions: Acute Kidney Injury
Hypertension
Chronic Kidney Disease

Interventions: Drug: Iodohippurate
Procedure: 24 hour ambulatory Blood Pressure
Procedure: Pulse Wave Velocity
Procedure: Peripheral Arterial Tonometry
Drug: Gadolinium

First Posted Date: 2015-11-06

Last Posted Date: 2020-12-09

Lead Sponsor: University of Florida

Registration Number: NCT02598674

Locations: 🇺🇸
UF Health, Gainesville, Florida, United States

An Integrated-Delivery-of-Care Approach to Improve Patient Outcomes, Safety, Well-Being After Orthopaedic Trauma

Not Applicable

Completed

Conditions: Musculoskeletal Injury Trauma

Interventions: Procedure: Usual Care (UsCare)
Procedure: Integrated care (ICare)
Other: Patient-Reported Outcomes Measurement Information System
Other: Lower Extremity Gain Scale (LEGS)
Other: Dynamometer
Other: Active Range of Motion (AROM)
Other: Posttraumatic Stress Disorder (PTSD)
Other: Beck Depression Inventory-II
Other: State-Trait Anxiety Inventory (STAI)
Other: Tampa Scale of Kinesiophobia-11 (TSK-11)

First Posted Date: 2015-10-29

Last Posted Date: 2024-10-28

Lead Sponsor: University of Florida

Target Recruit Count: 88

Registration Number: NCT02591472

Locations: 🇺🇸
UF and Shands Orthopaedics and Sports Medicine Institute, Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy